IN2014DN07866A - - Google Patents

Info

Publication number
IN2014DN07866A
IN2014DN07866A IN7866DEN2014A IN2014DN07866A IN 2014DN07866 A IN2014DN07866 A IN 2014DN07866A IN 7866DEN2014 A IN7866DEN2014 A IN 7866DEN2014A IN 2014DN07866 A IN2014DN07866 A IN 2014DN07866A
Authority
IN
India
Prior art keywords
level
proliferation
inhibition
sample
translation initiation
Prior art date
Application number
Inventor
Jose A Halperin
Michael Chorev
Huseyin Aktas
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of IN2014DN07866A publication Critical patent/IN2014DN07866A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02Food
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for determining the translation initiation inhibitory potency of a composition having an unknown level of translation initiation inhibitory activity which comprises contacting an e1-F2a-WT cell with said composition for a time and at a temperature effective to inhibit proliferation of said cell measuring the level of inhibition of proliferation of said e1-F2a-WT cells induced by said sample and comparing the level of inhibition of proliferation induced by said sample with the level of inhibition of proliferation induced by a standard having a known amount of said activity the amount of said translation initiation inhibitory activity in said sample being proportional to the level of inhibition of proliferation of said e1-F2a-WT cell.
IN7866DEN2014 2012-07-20 2013-07-22 IN2014DN07866A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261674180P 2012-07-20 2012-07-20
PCT/US2013/051433 WO2014015328A1 (en) 2012-07-20 2013-07-22 Cell based quality control bioassays for nutriceutical and medicinal products

Publications (1)

Publication Number Publication Date
IN2014DN07866A true IN2014DN07866A (en) 2015-04-24

Family

ID=48916225

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7866DEN2014 IN2014DN07866A (en) 2012-07-20 2013-07-22

Country Status (22)

Country Link
US (1) US9952200B2 (en)
EP (1) EP2820418B1 (en)
JP (1) JP6200501B2 (en)
KR (1) KR102136763B1 (en)
CN (1) CN104641231B (en)
AU (1) AU2013292266B2 (en)
CA (1) CA2866175C (en)
CL (1) CL2014002530A1 (en)
CO (1) CO7151536A2 (en)
DK (1) DK2820418T3 (en)
ES (1) ES2656941T3 (en)
HU (1) HUE036166T2 (en)
IN (1) IN2014DN07866A (en)
MA (1) MA35924B1 (en)
MX (1) MX356147B (en)
NO (1) NO2912013T3 (en)
PE (1) PE20142297A1 (en)
PL (1) PL2820418T3 (en)
PT (1) PT2820418T (en)
RU (1) RU2662358C2 (en)
WO (1) WO2014015328A1 (en)
ZA (1) ZA201406653B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107217087B (en) * 2016-03-22 2019-12-10 中国石油化工股份有限公司 method for rapidly measuring bacterial content in oilfield sewage and finished oil
CN115785247B (en) * 2022-12-22 2025-06-24 中国农业大学 A porcine epidemic diarrhea virus resistance-related protein EIF2A and its related biological materials and applications

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318846A (en) 1979-09-07 1982-03-09 Syva Company Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US5091519A (en) 1986-05-01 1992-02-25 Amoco Corporation Nucleotide compositions with linking groups
US5151507A (en) 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5066580A (en) 1988-08-31 1991-11-19 Becton Dickinson And Company Xanthene dyes that emit to the red of fluorescein
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
US5654419A (en) 1994-02-01 1997-08-05 The Regents Of The University Of California Fluorescent labels and their use in separations
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5847162A (en) 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6426513B1 (en) 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
US6815064B2 (en) 2001-07-20 2004-11-09 Quantum Dot Corporation Luminescent nanoparticles and methods for their preparation
WO2007008221A2 (en) * 2004-08-10 2007-01-18 President And Fellows Of Harvard College DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES
WO2008008333A2 (en) * 2006-07-11 2008-01-17 President And Fellows Of Harvard College Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation
CN105969847B (en) * 2009-04-17 2021-08-27 哈佛大学 Quality control bioassays for nutraceutical and pharmaceutical products
US9421211B2 (en) * 2009-05-28 2016-08-23 President And Fellows Of Harvard College N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
CN101671669B (en) * 2009-08-27 2012-05-02 浙江大学 A liver cancer targeting gene expression element AE and its application

Also Published As

Publication number Publication date
AU2013292266B2 (en) 2019-01-03
MX2014012542A (en) 2014-11-21
US9952200B2 (en) 2018-04-24
CL2014002530A1 (en) 2015-01-09
EP2820418B1 (en) 2017-12-06
JP6200501B2 (en) 2017-09-20
CN104641231A (en) 2015-05-20
KR102136763B1 (en) 2020-08-13
ES2656941T3 (en) 2018-03-01
PE20142297A1 (en) 2014-12-19
WO2014015328A1 (en) 2014-01-23
US20150301023A1 (en) 2015-10-22
DK2820418T3 (en) 2018-02-12
AU2013292266A1 (en) 2014-09-25
HUE036166T2 (en) 2018-06-28
PT2820418T (en) 2018-02-12
MA35924B1 (en) 2014-12-01
NO2912013T3 (en) 2018-03-10
CA2866175C (en) 2021-04-20
CO7151536A2 (en) 2014-12-29
KR20150035496A (en) 2015-04-06
CA2866175A1 (en) 2014-01-23
CN104641231B (en) 2016-09-07
JP2015524269A (en) 2015-08-24
PL2820418T3 (en) 2018-05-30
EP2820418A1 (en) 2015-01-07
RU2662358C2 (en) 2018-07-25
MX356147B (en) 2018-05-15
RU2014136408A (en) 2016-09-10
ZA201406653B (en) 2022-05-25

Similar Documents

Publication Publication Date Title
CO6680668A2 (en) Biomarker assays to detect or measure inhibition of tor kinase activity
NZ630026A (en) Inhibition of the glycine cleavage system for treatment of cancer
GB2519906A (en) Methods and systems for detecting biological components
SI4026917T1 (en) A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis
EP2921844A4 (en) Method and instrument for simultaneously measuring mercury and cadmium by direct sample injection
BR112016029634A2 (en) liver cancer detection kit, device and method
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
GB2544250A (en) Systems and methods for real-time measurement of gas content in drilling fluids
BR112013021666A2 (en) capacitance detection in electrochemical assay with improved sampling time compensation
GB201305388D0 (en) Benchmarks for normal cell identification
MX385004B (en) IBS SENSITIVITY TESTING COMPOSITIONS, DEVICES, AND METHODS
EP3190416A4 (en) Biomarker for predicting sensitivity to protein kinase inhibitor and use thereof
BR112012021590A2 (en) capacitance detection in electrochemical assay
PH12015501778A1 (en) Markers associated with wnt inhibitors
MX2012011326A (en) System and method for anti-cancer drug candidate evaluation.
EA201401201A1 (en) METHOD
EP3652339A4 (en) Biosensors for measuring cell signaling in stressed and healthy cells
BR112017023473A2 (en) nucleic acid detection and quantification method and compositions
GB201206323D0 (en) Methods and arrays for use in the same
UA103283C2 (en) Method for determination of components of cell wall of yeast
IN2014DN07866A (en)
BR112015020054A2 (en) METHOD OF DETECTING RESISTANCE TO THE THERAPEUTIC EFFECTS OF AN AKT INHIBITOR IN A CANCER CELL
GB201201593D0 (en) Evaluating and optimizing a trajectory function
EP2836610A4 (en) Methods for measuring polymerase activity useful for sensitive, quantitative measurements of any polymerase extension activity and for determining the presence of viable cells